RQA features a session from IMPALA Consortium titled "Overview of IMPALA Industry Group and its impact on modernizing GCP/PV Quality." The session features Timothe Menard (Roche), Maria Brynildsen (Sanofi), and Michael Pelosi (Astellas). The session discusses the industry needs that [...]
IMPALA Consortium will be attending DIA 2023 in June in three sessions featuring speakers from member companies of IMPALA. we will have three sessions with speakers from companies that are members of the industry group. Check out the sessions below [...]
IEEE Spectrum, IEEE's leading magazine on technology and science, interviews IMPALA Consortium representatives on how the Consortium is bringing together leading pharmaceutical companies to streamline the QA process for drug approval.
The write-up on the recent RQA Workshop on Data Analytics is now available. The workshop took place at the RQA Conference in Brighton in November 2022, and was facilitated by Jennifer Emerson (Boehringer Ingelheim), Joanne North (BMS), Paula Walker (Roche), [...]
In the IMPALA Clinical Safety Reporting workstream, we want to promote the use of advanced analytics to detect quality risk in clinical trials related to safety reporting. Pivotal to all clinical trials is the reporting of adverse events (AE.) Information [...]
